25.53
25.53 (0%)
As of Feb 14, 2025
PFIZER INC [PFE]
Source:
Company Overview
Pfizer Inc. is a research-based, global biopharmaceutical company. We apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | (212) 733-2323 |
| Industry | manufacturing |
| CEO | Albert Bourla Albert Bourla |
| Website | www.pfizer.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $63,627 |
| Operating Profit | |
| Net Income | $8,062 |
| Net Cash | $-1,810 |
Profit Ratios
| Gross Margin | $45,776 |
| Operating Margin | |
| Profit as % of Revenues | 567.8% |
| Profit as % of Assets | 3.7% |
| Profit as % of Stockholder Equity | 9.1% |
Management Effectiveness
| Return on Equity | 9.1% |
| Return on Assets | 3.8% |
| Turnover Ratio | 28.9% |
| EBITA | $5,286 |
Balance Sheet and Cash Flow Measures
| Total Assets | $213,396 |
| Total Liabilities | $124,899 |
| Operating Cash Flow | $12,744 |
| Investing Cash Flow | $2,652 |
| Financing Cash Flow | $-17,140 |
